TSXV:HVT

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Harvest One Cannabis Inc., through its subsidiaries, develops and provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. More Details


Snowflake Analysis

Mediocre balance sheet and overvalued.

Share Price & News

How has Harvest One Cannabis's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: HVT is more volatile than 75% of Canadian stocks over the past 3 months, typically moving +/- 18% a week.

Volatility Over Time: HVT's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of Canadian stocks.


Market Performance


7 Day Return

7.7%

HVT

16.1%

CA Pharmaceuticals

2.6%

CA Market


1 Year Return

-65.9%

HVT

23.2%

CA Pharmaceuticals

0.5%

CA Market

Return vs Industry: HVT underperformed the Canadian Pharmaceuticals industry which returned 14.8% over the past year.

Return vs Market: HVT underperformed the Canadian Market which returned -0.3% over the past year.


Shareholder returns

HVTIndustryMarket
7 Day7.7%16.1%2.6%
30 Day40.0%39.0%13.3%
90 Day-6.7%35.4%6.0%
1 Year-65.9%-65.9%23.2%23.2%4.2%0.5%
3 Year-92.4%-92.4%-23.4%-24.6%13.0%2.0%
5 Yearn/a292.9%290.0%49.8%26.8%

Long-Term Price Volatility Vs. Market

How volatile is Harvest One Cannabis's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Harvest One Cannabis undervalued compared to its fair value and its price relative to the market?

0.45x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate HVT's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate HVT's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: HVT is unprofitable, so we can't compare its PE Ratio to the CA Pharmaceuticals industry average.

PE vs Market: HVT is unprofitable, so we can't compare its PE Ratio to the Canadian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate HVT's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: HVT is good value based on its PB Ratio (0.4x) compared to the CA Pharmaceuticals industry average (1.5x).


Next Steps

Future Growth

How is Harvest One Cannabis forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

60.6%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Harvest One Cannabis has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Harvest One Cannabis performed over the past 5 years?

-66.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: HVT is currently unprofitable.

Growing Profit Margin: HVT is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: HVT is unprofitable, and losses have increased over the past 5 years at a rate of 66% per year.

Accelerating Growth: Unable to compare HVT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: HVT is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-45%).


Return on Equity

High ROE: HVT has a negative Return on Equity (-171.65%), as it is currently unprofitable.


Next Steps

Financial Health

How is Harvest One Cannabis's financial position?


Financial Position Analysis

Short Term Liabilities: HVT's short term assets (CA$28.4M) exceed its short term liabilities (CA$19.2M).

Long Term Liabilities: HVT's short term assets (CA$28.4M) exceed its long term liabilities (CA$2.1M).


Debt to Equity History and Analysis

Debt Level: HVT's debt to equity ratio (14.7%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if HVT's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: HVT has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: HVT has less than a year of cash runway if free cash flow continues to reduce at historical rates of 50% each year


Next Steps

Dividend

What is Harvest One Cannabis's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate HVT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate HVT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if HVT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if HVT's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of HVT's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.1yrs

Average management tenure


CEO

Gord Davey

0.083

Tenure

Mr. Gord Davey has been President, Interim Chief Executive Officer and Director at Harvest One Cannabis Inc. since October 9, 2020. Mr. Davey was the Senior Vice President of Global Sales at Harvest One Ca...


Leadership Team

NamePositionTenureCompensationOwnership
Frank Holler
Executive Chairman1.92yrsCA$26.38kno data
Christopher Podolsky
no dataCA$331.48kno data
Gord Davey
President0.083yrno datano data
Marc Tran
Interim Chief Financial Officer0.33yrno datano data
Nick Maltchev
Chief technology Officer3.5yrsCA$171.02kno data
Colin Clancy
Vice President of Investor Relationsno datano datano data
Ann Gallery
Senior Vice President of Corporate Communications2.17yrsno datano data
Will Stewart
Senior Vice President of Corporate & Public Affairs2.08yrsCA$30.00kno data
Marien Segovia
Corporate Secretary2.08yrsno datano data
Kwong Choo
Vice President of Finance3.42yrsCA$95.37kno data

2.1yrs

Average Tenure

52yo

Average Age

Experienced Management: HVT's management team is considered experienced (2.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Frank Holler
Executive Chairman1.92yrsCA$26.38kno data
Gord Davey
President0.083yrno datano data
Jason Bednar
Independent Director3.58yrsCA$36.00kno data
David Hyde
Member of the Advisory Board2.17yrsno datano data
Andrew Bayfield
Director0.67yrno datano data

1.9yrs

Average Tenure

Experienced Board: HVT's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Harvest One Cannabis Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Harvest One Cannabis Inc.
  • Ticker: HVT
  • Exchange: TSXV
  • Founded:
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: CA$12.905m
  • Shares outstanding: 215.08m
  • Website: https://www.harvestone.com

Number of Employees


Location

  • Harvest One Cannabis Inc.
  • 885 West Georgia Street
  • Suite 1400
  • Vancouver
  • British Columbia
  • V6C 3E8
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
HVTTSXV (TSX Venture Exchange)YesCommon SharesCACADApr 2017
HRVO.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDApr 2017
2CNDB (Deutsche Boerse AG)YesCommon SharesDEEURApr 2017

Biography

Harvest One Cannabis Inc., through its subsidiaries, develops and provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. It operates through two segments, Medica...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/11/27 23:18
End of Day Share Price2020/11/27 00:00
Earnings2020/06/30
Annual Earnings2020/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.